505 related articles for article (PubMed ID: 12084461)
21. Time course of inhibition of thymidylate synthase in patients treated with fluorouracil and leucovorin.
Peters GJ; van Groeningen CJ; van der Wilt CL; Meijer S; Smid K; Laurensse E; Pinedo HM
Semin Oncol; 1992 Apr; 19(2 Suppl 3):26-35. PubMed ID: 1557655
[TBL] [Abstract][Full Text] [Related]
22. Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors.
Van der Wilt CL; Pinedo HM; Smid K; Peters GJ
Cancer Res; 1992 Sep; 52(18):4922-8. PubMed ID: 1516048
[TBL] [Abstract][Full Text] [Related]
23. Chronic exposure of colorectal cancer cells in culture to fluoropyrimidine analogs induces thymidylate synthase and suppresses p53. A molecular explanation for the mechanism of 5-FU resistance.
Subbarayan PR; Sarkar M; Nelson G; Benitez E; Singhal S; Ardalan B
Anticancer Res; 2010 Apr; 30(4):1149-56. PubMed ID: 20530421
[TBL] [Abstract][Full Text] [Related]
24. Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil.
Peters GJ; van der Wilt CL; van Groeningen CJ; Smid K; Meijer S; Pinedo HM
J Clin Oncol; 1994 Oct; 12(10):2035-42. PubMed ID: 7931471
[TBL] [Abstract][Full Text] [Related]
25. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
Jackman AL; Alison DL; Calvert AH; Harrap KR
Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
[TBL] [Abstract][Full Text] [Related]
26. Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors.
Kadota K; Huang CL; Liu D; Yokomise H; Haba R; Wada H
Int J Oncol; 2011 Feb; 38(2):355-63. PubMed ID: 21174056
[TBL] [Abstract][Full Text] [Related]
27. Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed.
Peters GJ; van Triest B; Backus HH; Kuiper CM; van der Wilt CL; Pinedo HM
Eur J Cancer; 2000 May; 36(7):916-24. PubMed ID: 10785598
[TBL] [Abstract][Full Text] [Related]
28. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.
Banerjee D; Mayer-Kuckuk P; Capiaux G; Budak-Alpdogan T; Gorlick R; Bertino JR
Biochim Biophys Acta; 2002 Jul; 1587(2-3):164-73. PubMed ID: 12084458
[TBL] [Abstract][Full Text] [Related]
29. 5-fluorouracil/leucovorin-induced inhibition of thymidylate synthase in normal tissues of mouse and man.
van der Wilt CL; van Groeningen CJ; Pinedo HM; Smid K; Hoekman K; Meijer S; Peters GJ
J Cancer Res Clin Oncol; 1997; 123(11-12):595-601. PubMed ID: 9620216
[TBL] [Abstract][Full Text] [Related]
30. Thymidylate synthase: a target for combination therapy and determinant of chemotherapeutic response in colorectal cancer.
Van Triest B; Peters GJ
Oncology; 1999 Oct; 57(3):179-94. PubMed ID: 10545786
[TBL] [Abstract][Full Text] [Related]
31. Functional inactivity and mutations of p53 differentially affect sensitivity to 5-fluorouracil and antifolate inhibitors of thymidylate synthase (TS) by altering TS levels in colorectal cancer cells.
Giovannetti E; Backus HH; Wouters D; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):740-5. PubMed ID: 18600534
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis and thymidylate synthase inductions by 5-fluorouracil in gastric cancer cells with or without p53 mutation.
Yukimoto K; Nakata B; Muguruma K; Yashiro M; Ohira M; Ishikawa T; Hino M; Hirakawa K
Int J Oncol; 2001 Aug; 19(2):373-8. PubMed ID: 11445854
[TBL] [Abstract][Full Text] [Related]
33. Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed.
Di Gennaro E; Bruzzese F; Pepe S; Leone A; Delrio P; Subbarayan PR; Avallone A; Budillon A
Cancer Biol Ther; 2009 May; 8(9):782-91. PubMed ID: 19270508
[TBL] [Abstract][Full Text] [Related]
34. Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells.
Inaba M; Mitsuhashi J; Sawada H; Miike N; Naoe Y; Daimon A; Koizumi K; Tsujimoto H; Fukushima M
Jpn J Cancer Res; 1996 Feb; 87(2):212-20. PubMed ID: 8609072
[TBL] [Abstract][Full Text] [Related]
35. Selective protection by uridine of growth inhibition by 5-fluorouracil (5FU) mediated by 5FU incorporation into RNA, but not the thymidylate synthase mediated growth inhibition by 5FU-leucovorin.
Codacci-Pisanelli G; Noordhuis P; van der Wilt CL; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):733-9. PubMed ID: 18600533
[TBL] [Abstract][Full Text] [Related]
36. Polymorphism of the thymidylate synthase gene and thymidylate synthase levels in colon cancer cell lines and different tissues of colorectal cancer patients.
Mauritz R; Beumer IJ; Marsh S; McLeod HL; Smid K; van Groeningen CJ; Pinedo HM; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1381-4. PubMed ID: 15571263
[TBL] [Abstract][Full Text] [Related]
37. A rationale for the clinical development of the thymidylate synthase inhibitor ZD9331 in ovarian and other solid tumours.
Jackman AL; Melin CJ; Kimbell R; Brunton L; Aherne GW; Theti DS; Walton M
Biochim Biophys Acta; 2002 Jul; 1587(2-3):215-23. PubMed ID: 12084463
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase.
Nakamura A; Nakajima G; Okuyama R; Kuramochi H; Kondoh Y; Kanemura T; Takechi T; Yamamoto M; Hayashi K
Gastric Cancer; 2014 Jan; 17(1):188-95. PubMed ID: 23494117
[TBL] [Abstract][Full Text] [Related]
39. Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil. Is it time to move forward?
Showalter SL; Showalter TN; Witkiewicz A; Havens R; Kennedy EP; Hucl T; Kern SE; Yeo CJ; Brody JR
Cancer Biol Ther; 2008 Jul; 7(7):986-94. PubMed ID: 18443433
[TBL] [Abstract][Full Text] [Related]
40. Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil.
Cascinu S; Aschele C; Barni S; Debernardis D; Baldo C; Tunesi G; Catalano V; Staccioli MP; Brenna A; Muretto P; Catalano G
Clin Cancer Res; 1999 Aug; 5(8):1996-9. PubMed ID: 10473077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
